Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data.
Saved in:
| Title: | Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data. |
|---|---|
| Authors: | Colinet B; Department of Pneumology and Thoracic Oncology, Grand Hôpital de Charleroi, Gilly, Belgium., Van Meerbeeck JP; Department of Pulmonology and Thoracic Oncology, Antwerp University Hospital, Edegem and Antwerp University, Antwerp, Belgium., Cuppens T; Medical Department, AstraZeneca Belux, Belgium and Luxemburg., Vansteenkiste JF; Respiratory Oncology Unit, Department of Respiratory Diseases, University Hospitals KU Leuven, Catholic University Leuven, Leuven, Belgium. |
| Source: | Acta clinica Belgica [Acta Clin Belg] 2021 Jun; Vol. 76 (3), pp. 224-231. Date of Electronic Publication: 2020 Jan 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 0370306 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2295-3337 (Electronic) Linking ISSN: 17843286 NLM ISO Abbreviation: Acta Clin Belg Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2295-3337 |
|---|---|
| DOI: | 10.1080/17843286.2019.1708125 |
